Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel zinc-catalyzed route for high-purity chiral bisphosphonamides offering scalable manufacturing solutions for asymmetric catalysis applications in pharma.
Patent CN107641100A details a mild copper-catalyzed route for 6-cyanophenanthridine. This method offers significant supply chain stability and cost advantages for pharmaceutical manufacturing.
Patent CN102206189A details a green copper-catalyzed route for phenazine derivatives in water, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN107383005B reveals a green one-step synthesis for high-purity Zolpidem intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN116082152B reveals a novel photocatalytic route for ethyl pyruvate. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110698451A reveals a novel P2O5 cyclization method for Baloxavir intermediates. Achieve high purity, low waste, and cost reduction in API manufacturing.
Patent CN110981707A details a novel isomerization method for high-purity chiral citronellal. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN1974567B details a safer, scalable synthesis of Sertaconazole Nitrate using NaOH/Isopropanol, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel 4-step synthesis of Idelalisib eliminates metal residues and reduces costs. Ideal for reliable API intermediate suppliers seeking green manufacturing.
Patent CN104592222B reveals a cost-effective AZD6482 route using chiral sulfinamide. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN113336792B reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonate compounds, offering superior stereoselectivity and scalable manufacturing for NASH therapeutics.
Patent CN104557737B details a high-yield Pd-catalyzed route for quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105541685B reveals high-yield iridium-catalyzed trifluoromethylation. Delivers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed route for polyaryl sulfone intermediates offers safer processing and significant cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110922305A reveals a novel route for 5-bromo-2-chloro-4'-ethoxy diphenylmethane, eliminating ortho-impurities and ensuring high-purity API intermediates.
Novel room-temperature mesylation route for Ertapenem side chain. Reduces cryogenic costs and simplifies purification for scalable API manufacturing.
Patent CN107880046B details a CSA-catalyzed route for dibenzo azepines offering high yields and simplified processing for scalable pharmaceutical intermediate manufacturing supply chains.
Novel catalytic route for high-purity geranylgeraniol production. Reduces costs and improves scalability for pharmaceutical intermediates manufacturing.
Patent CN118028403A reveals high-purity NMN synthesis via immobilized enzyme. Offers significant cost reduction and supply chain reliability for nutraceutical manufacturers.
Patent CN109136311B reveals cost-effective SAM production. Adenosine substrate replaces ATP. Reliable supplier for pharma intermediates.